BioNTech SE is 11.2x more valuable than Vericel Corp by market capitalization ($22.18 B vs $1.98 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VCEL | BNTX |
|---|---|---|
| Market cap | $1.98 B | $22.18 B |
| US-listed rank | #2116 | #582 |
| Revenue (latest FY) | $276.26M | - |
| Net income (latest FY) | $16.52M | - |
| Net margin | 6.0% | - |
| P/E (trailing FY) | 119.6 | - |
| SEC filings | 1,674 | 548 |
BioNTech SE is 11.2x more valuable than Vericel Corp by market capitalization ($22.18 B vs $1.98 B).
Full pages: Vericel Corp and BioNTech SE, or browse the full rankings.